Company Update (NASDAQ:ALXN): Alexion Announces the Passing of Max Link, Ph.D., Chairman of the Company’s Board of Directors

[Business Wire] – Alexion Pharmaceuticals, Inc. today announced that Max Link, Ph.D., Chairman of the Board of Directors of Alexion, passed away unexpectedly on October 5 while traveling on business. Read more on . . . → Read More: Company Update (NASDAQ:ALXN): Alexion Announces the Passing of Max Link, Ph.D., Chairman of the Company’s Board of Directors Similar Articles: Market Update (NASDAQ:ALXN): Alexion Strengthens and Broadens Its Executive Leadership Team Company Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Asfotase Alfa Granted Orphan Drug Designation in Japan Stock Update (NASDAQ:ALXN): Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function (DGF) after Kidney Transplantation